Early vancomycin-resistant enterococcus (VRE) bacteremia after allogeneic bone marrow transplantation is associated with a rapidly deteriorating clinical course

Bone Marrow Transplantation

Volumn 35, Issue 5, 2005, Pages 497-499

  Avery, R ^a   Kalaycio, M ^a   Pohlman, B ^a   Sobecks, R ^a   Kuczkowski, E ^a   Andresen, S ^a   Mossad, S ^a   Shamp, J ^a   Curtis, J ^a   Kosar, J ^a   Sands, K ^a   Serafin, M ^a   Bolwell, B ^a  

^a LERNER RESEARCH INSTITUTE   (United States)

Author keywords

Allogeneic bone marrow transplant; Toxicity; Vancomycin resistant enterococcal infection

Indexed keywords

ACICLOVIR; AMPHOTERICIN; AMPICILLIN; BUSULFAN; CD8 ANTIGEN; CHLORAMPHENICOL; COTRIMOXAZOLE; CYCLOPHOSPHAMIDE; DALFOPRISTIN PLUS QUINUPRISTIN; ETOPOSIDE; GENTAMICIN; LINEZOLID; METHOTREXATE; PIPERACILLIN PLUS TAZOBACTAM; STREPTOMYCIN; TACROLIMUS; VANCOMYCIN;

ACUTE LEUKEMIA; ADULT RESPIRATORY DISTRESS SYNDROME; ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION; ANTIBIOTIC THERAPY; BACTEREMIA; BACTERIAL INFECTION; BACTERIUM CULTURE; CANCER REGRESSION; CANCER RELAPSE; CAUSE OF DEATH; CONTROLLED STUDY; DISEASE COURSE; FEBRILE NEUTROPENIA; GRAFT VERSUS HOST REACTION; HIGH RISK PATIENT; HUMAN; INCIDENCE; INFECTION RISK; LEUKEMIA RELAPSE; LEUKEMIA REMISSION; LEUKOCYTE COUNT; LYMPHOCYTE DEPLETION; MAJOR CLINICAL STUDY; MEDICAL RECORD; MULTIPLE ORGAN FAILURE; MYCOSIS; MYELODYSPLASTIC SYNDROME; NEUTROPHIL; NONHODGKIN LYMPHOMA; PRIORITY JOURNAL; REVIEW; SURVIVAL RATE; T LYMPHOCYTE; THROMBOCYTE; TIME; VANCOMYCIN RESISTANT ENTEROCOCCUS; VIRUS INFECTION;

BACTEREMIA; BONE MARROW TRANSPLANTATION; CAUSE OF DEATH; DISEASE PROGRESSION; DRUG RESISTANCE; ENTEROCOCCUS FAECALIS; HEMATOLOGIC NEOPLASMS; HUMANS; INCIDENCE; MALE; MIDDLE AGED; PERIPHERAL BLOOD STEM CELL TRANSPLANTATION; RETROSPECTIVE STUDIES; TRANSPLANTATION, HOMOLOGOUS; VANCOMYCIN;

EID: 20144365123     PISSN: 02683369     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.bmt.1704821     Document Type: Review

References (15)

1. Zinner SH. Changing epidemiology of infections in patients with neutropenia and cancer: emphasis on Gram-positive and resistant bacteria. Clin Infect Dis 1999; 29: 490-494.
2. Shlaes DM, Binczewski B, Rice LB. Emerging antimicrobial resistance and the immunocompromised host. Clin Infect Dis 1993; 17 (Suppl 2): S527-S536.
3. Frere P, Hermanne JP, Debouge MH et al. Changing pattern of bacterial susceptibility to antibiotics in hematopoietic stem cell transplant recipients. Bone Marrow Transplant 2002; 29: 589-594.
4. Morris Jr JG, Shay DK, Hebden JN et al. Enterococci resistant to multiple antimicrobial agents, including vancomycin. Establishment of endemicity in a university medical center. Ann Intern Med 1995; 123: 250-259.
5. Edmond MB, Ober JF, Weinbaum DL et al. Vancomycin-resistant Enterococcus faecium bacteremia: risk factors for infection. Clin Infect Dis 1995; 20: 1126-1133.
6. Kapur D, Dorsky D, Feingold JM et al. Incidence and outcome of vancomycin-resistant enterococcal bacteremia following autologous peripheral blood stem cell transplantation. Bone Marrow Transplant 2000; 25: 147-152.
7. Peetermans WE, Sebens FW, Guiot HF. Vancomycin-resistant Enterococcus faecalis in a bone-marrow transplant recipient. Scand J Infect Dis 1991; 23: 105-109.
8. Koc Y, Snydman DR, Schenkein DS, Miller KB. Vancomycin-resistant enterococcal infections in bone marrow transplant recipients. Bone Marrow Transplant 1998; 22: 207-209.
9. Kirkpatrick BD, Harrington SM, Smith D et al. An outbreak of vancomycin-dependent Enterococcus faecium in a bone marrow transplant unit. Clin Infect Dis 1999; 29: 1268-1273.
10. McNeil SA, Clark NM, Chandrasekar PH, Kauffman CA. Successful treatment of vancomycin-resistant Enterococcus faecium bacteremia with linezolid after failure of treatment with synercid (quinupristin/dalfopristin). Clin Infect Dis 2000; 30: 403-404.
11. Hachem R, Afif C, Gokaslan Z, Raad I. Successful treatment of vancomycin-resistant Enterococcus meningitis with line-zolid. Eur J Clin Microbiol Infect Dis 2001; 20: 432-434.
12. Hachem RY, Hicks K, Huen A, Raad I. Myelosuppression and serotonin syndrome associated with concurrent use of linezolid and selective serotonin reuptake inhibitors in bone marrow transplant recipients. Clin Infect Dis 2003; 37: e8-e11.
13. Manzella JP. Quinupristin-dalfopristin: a new antibiotic for severe Gram-positive infections. Am Fam Physician 2001; 64: 1863-1866.
14. Howe RA, Robson M, Oakhill A et al. Successful use of tetracycline as therapy of an immunocompromised patient with septicaemia caused by a vancomycin-resistant enterococcus. J Antimicrob Chemother 1997; 40: 144-145.
15. Montecalvo MA. Ramoplanin: a novel antimicrobial agent with the potential to prevent vancomycin-resistant enterococcal infection in high-risk patients. J Antimicrob Chemother 2003; 51: iii31-iii35.